Literature DB >> 1535443

Population characteristics of biological systems influenced by multicomponent random and uniform variation.

G M Kochak1.   

Abstract

The total variability associated with the pharmacokinetic disposition of seven therapeutic agents was decomposed into its source components. After differentiating and isolating random components from fixed uniform components of variance, the proportional contribution of random intersubject and intrasubject variance was evaluated. Statistical analysis utilized a mixed-effects probabilistic model which incorporated both random effects and fixed day-to-day effects. In some cases, time-within-day diurnal effects were also incorporated. While significant intersubject effects were found for all seven drugs studied, three of them were characterized by predominant intrasubject variance. Since intrasubject variance represents a measure of the stability of drug disposition, characterization of its relative magnitude is fundamentally important in assessing the therapeutic consequences of a given treatment at any given time. Significant diurnal effects were found which were strikingly invariant.

Mesh:

Substances:

Year:  1992        PMID: 1535443     DOI: 10.1023/a:1015838802045

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Intra- and intersubject variability: mixed-effects statistical analysis of repeated doses of an angiotensin converting enzyme inhibitor, CGS 16617.

Authors:  G M Kochak; R A Smith; R L Choi; V John; V Tipnis; F Honc; J K deSilva; D J Weidler
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

2.  Intraindividual variation in drug disposition.

Authors:  A P Alvares; A Kappas; J L Eiseman; K E Anderson; C B Pantuck; E J Pantuck; K C Hsiao; W A Garland; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

3.  Single-dose pharmacokinetics of terodiline, including a stable isotope technique for improvement of statistical evaluations.

Authors:  B Hallén; O Guilbaud; S Strömberg; B Lindeke
Journal:  Biopharm Drug Dispos       Date:  1988 May-Jun       Impact factor: 1.627

Review 4.  Genetic and environmental factors affecting drug disposition in man.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

5.  Chronopharmacokinetic study of a prolonged release form of indomethacin.

Authors:  P Guissou; G Cuisinaud; G Llorca; E Lejeune; J Sassard
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Pharmacogenetics: multiple interactions between genes and environment as determinants of drug response.

Authors:  E S Vesell
Journal:  Am J Med       Date:  1979-02       Impact factor: 4.965

7.  An aid to decision-making in bioequivalence assessment.

Authors:  H Fluehler; J Hirtz; H A Moser
Journal:  J Pharmacokinet Biopharm       Date:  1981-04

8.  Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.

Authors:  M Eichelbaum; T Tomson; G Tybring; L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

9.  Comparative bioavailability of trazodone formulations using stable isotope methodology.

Authors:  R E Gammans; A V Mackenthun; J W Russell
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

10.  Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.

Authors:  B F Bourgeois; N Wad
Journal:  Ther Drug Monit       Date:  1984       Impact factor: 3.681

View more
  1 in total

1.  Dose proportionality and population characteristics of oral fadrozole hydrochloride, an aromatase inhibitor, in postmenopausal women.

Authors:  G M Kochak; R L Choi; E A Entwistle
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.